Portfolio tool

Your portfolios

This content is for subscribers only. Register for free trial period. Registering for a trial version is completely free.

RegisterLogin

Sample Portfolios

The portfolios below constitute samples only, of how each user can create any portfolio for own monitoring and use. The portfolios are not in any way subject for active portfolio management, describing only a situation at a specific point in history, and hence, is not a recommendation, and do not enable imitation of a portfolio or a therein presented strategy.

Sample Portfolio - Pharmaceutical companies

Portfolio content and return

The portfolio below constitute a sample only, of how each user can create any portfolio for own monitoring and use. The portfolio is not in any way subject for active portfolio management, describing only a situation at a specific point in history, and hence, is not a recommendation, and do not enable imitation of the portfolio or a therein presented strategy.

Ten leading pharmaceutical companies. These are the companies that develop and manufacture life saving medicines used all over the world. Despite the important task performed by this industry it has however also encountered varying cycles on the stock exchange. Recent years have been good whereas, e.g., the beginning of the 2010s was less good. Pharma companies have always been a classical safe haven choice on the stock market. An investment of 50.000 euros gives a dividend income of 1 457 euros, double the amount received from the “global brands” portfolio. (10.6.2022)

This content does not constitute investment research, financial analysis or investment advice. The content may not be considered as a recommendation to either buy or sell a stock or other investment instruments. No guarantees regarding the correctness of the content of can be given. In case the user wants to form an opinion regarding a stock or some other investment instrument for a possible investment decision, the user is herself responsible for this. In this case we recommend that the user, either by his own or together with his/her possible investment adviser, gathers additional information regarding the matter. Zenito Oy publishes content regarding subjects Zenito Oy considers interesting from some perspective. This does not mean that the subject, viewed objectively, is interesting or relevant.